Mehrotra R, Norris K
Division of Nephrology and Hypertension, Los Angeles Biomedical Research Center at Harbor-UCLA, Torrance, CA, USA.
Clin Nephrol. 2010 Nov;74 Suppl 1(Suppl 1):S95-8.
In the United States, there are significant racial disparities in the incidence and prevalence of end-stage renal disease. The disparities are greatest for the Blacks and the magnitude of disparity is significantly greater than is evident from the incidence and prevalence data of end-stage renal disease - early stage chronic kidney disease is less common in Blacks and during that stage, mortality rate is significantly higher for that racial group. Recent studies have identified a genetic predisposition for non-diabetic renal disease among Blacks. However, genetic factors explain only part of the higher risk and the racial disparities are a result of a complex interplay of biology and sociology. Herein we focus on two factors and their role in explaining the higher risk for progression of chronic kidney disease among Blacks - one biologic (vitamin D deficiency) and one sociologic (neighborhood poverty). A greater Understanding of these factors is important in order to reduce the racial disparities in the United States.
在美国,终末期肾病的发病率和患病率存在显著的种族差异。黑人的差异最为显著,且差异程度明显大于终末期肾病发病率和患病率数据所显示的情况——早期慢性肾病在黑人中不太常见,在此阶段,该种族群体的死亡率显著更高。最近的研究已经确定黑人存在非糖尿病肾病的遗传易感性。然而,遗传因素仅解释了部分较高风险,种族差异是生物学和社会学复杂相互作用的结果。在此,我们关注两个因素及其在解释黑人慢性肾病进展风险较高方面的作用——一个是生物学因素(维生素D缺乏),另一个是社会学因素(社区贫困)。更好地理解这些因素对于减少美国的种族差异很重要。